Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B

被引:15
作者
Kubo, S
Tanaka, H
Shuto, T
Takemura, S
Yamamoto, T
Kanazawa, A
Uenishi, T
Tanaka, S
Hirohashi, K
Nishiguchi, S
Kinoshita, H
机构
[1] Osaka City Univ, Grad Sch Med, Dept Gastroenterol & Hepatobiliary Pancreat Surg, Abeno Ku, Osaka 5458585, Japan
[2] Osaka City Univ, Grad Sch Med, Dept Hepatol, Abeno Ku, Osaka 5458585, Japan
关键词
hepatocellular carcinoma; liver resection; hepatitis B virus; alcohol abuse; diabetes mellitus;
D O I
10.1007/s00595-004-2919-x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose. We compared the clinicopathologic features affecting outcome after surgery for hepatocellular carcinoma (HCC) between patients with concurrent and previous chronic hepatitis B. Methods. Group A consisted of 58 patients with concurrent chronic hepatitis B, defined by seropositivity for the hepatitis B surface antigen (HBsAg), and group B consisted of 18 patients whose HCC was detected after disappearance of the HBsAg. We assessed the influence of various characteristics on outcome. Results. The mean age and percentage of patients suffering from alcohol abuse or diabetes mellitus were significantly greater in group B than in group A, whereas histologic hepatitis activity, hepatic fibrosis, and alanine aminotransferase activity were significantly lower in group B than in group A. The tumor-free survival rates were similar between the two groups, but the risk factors of recurrence differed. In group A, relative youth, high aspartate aminotransferase activity, low platelet count, multiple tumors, large tumor size, portal invasion, cirrhosis, nonanatomic resection, and positive surgical margin were risk factors. In group B, large tumor size and poor differentiation were risk factors. Conclusion. Hepatitis B status, tumor factors, and the type of operation affected cancer recurrence after surgery for HCC in patients with concurrent chronic HBV, as opposed to only tumor factors in patients with previous chronic hepatitis B.
引用
收藏
页码:216 / 222
页数:7
相关论文
共 40 条
[31]  
Sherlock, 1997, DIS LIVER BILIARY SY, V30, P61
[32]   Changes and results of surgical strategies for hepatocellular carcinoma: Results of a 15-year study on 452 consecutive patients [J].
Shuto, T ;
Hirohashi, K ;
Kubo, S ;
Tanaka, H ;
Tsukamoto, T ;
Yamamoto, T ;
Ikebe, T ;
Kinoshita, H .
SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1998, 28 (11) :1124-1129
[33]   Possible contribution to hepatocarcinogenesis of X transcript of hepatitis B virus in Japanese patients with hepatitis C virus [J].
Tamori, A ;
Nishiguchi, S ;
Kubo, S ;
Koh, N ;
Moriyama, Y ;
Fujimoto, S ;
Takeda, T ;
Shiomi, S ;
Hirohashi, K ;
Kinoshita, H ;
Otani, S ;
Kuroki, T .
HEPATOLOGY, 1999, 29 (05) :1429-1434
[34]   HBV DNA integratioin and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan [J].
Tamori, A ;
Nishiguchi, S ;
Kubo, S ;
Narimatsu, T ;
Habu, D ;
Takeda, T ;
Hirohashi, K ;
Shiomi, S .
JOURNAL OF MEDICAL VIROLOGY, 2003, 71 (04) :492-498
[35]   Sequencing of human-viral DNA junctions in hepatocellular carcinoma from patients with HCV and occult HBV infection [J].
Tamori, A ;
Nishiguchi, S ;
Kubo, S ;
Enomoto, M ;
Koh, N ;
Takeda, T ;
Shiomi, S ;
Hirohashi, K ;
Kinoshita, H ;
Otani, S .
JOURNAL OF MEDICAL VIROLOGY, 2003, 69 (04) :475-481
[36]   INCREASED SAFETY BY 2-STAGE HEPATECTOMY WITH PREOPERATIVE PORTAL-VEIN EMBOLIZATION IN RATS [J].
TANAKA, H ;
KINOSHITA, H ;
HIROHASHI, K ;
KUBO, S ;
LEE, KC .
JOURNAL OF SURGICAL RESEARCH, 1994, 57 (06) :687-692
[37]   Influence of histological inflammatory activity on regenerative capacity of liver after percutaneous transhepatic portal vein embolization [J].
Tanaka, H ;
Hirohashi, K ;
Kubo, S ;
Ikebe, T ;
Tsukamoto, T ;
Hamba, H ;
Shuto, T ;
Wakasa, K ;
Kinoshita, H .
JOURNAL OF GASTROENTEROLOGY, 1999, 34 (01) :100-104
[38]   Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function [J].
Tanaka, H ;
Hirohashi, K ;
Kubo, S ;
Shuto, T ;
Higaki, I ;
Kinoshita, H .
BRITISH JOURNAL OF SURGERY, 2000, 87 (07) :879-882
[39]  
Yano Y, 2002, AM J GASTROENTEROL, V97, P156, DOI 10.1111/j.1572-0241.2002.05440.x
[40]   NONVIRAL RISK-FACTORS FOR HEPATOCELLULAR-CARCINOMA IN A LOW-RISK POPULATION, THE NON-ASIANS OF LOS-ANGELES COUNTY, CALIFORNIA [J].
YU, MC ;
TONG, MJ ;
GOVINDARAJAN, S ;
HENDERSON, BE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (24) :1820-1826